Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Preference for a fixed combination of brinzolamide/timolol versus dorzolamide/timolol among patients with open-angle glaucoma or ocular hypertension.

Sanseau A, Sampaolesi J, Suzuki ER Jr, Lopes JF, Borel H.

Clin Ophthalmol. 2013;7:357-62. doi: 10.2147/OPTH.S38575. Epub 2013 Feb 18.

2.
3.

Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension.

Gugleta K.

Curr Med Res Opin. 2010 Jun;26(6):1255-67. doi: 10.1185/03007991003738485. Review.

PMID:
20350146
4.

Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension.

Holló G, Bozkurt B, Irkec M.

Expert Opin Pharmacother. 2009 Aug;10(12):2015-24. doi: 10.1517/14656560903124388. Review.

PMID:
19618994
5.

Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.

Ormrod D, McClellan K.

Drugs Aging. 2000 Dec;17(6):477-96. Review.

PMID:
11200308
6.

Latanoprost : an update of its use in glaucoma and ocular hypertension.

Perry CM, McGavin JK, Culy CR, Ibbotson T.

Drugs Aging. 2003;20(8):597-630. Review.

PMID:
12795627

Supplemental Content

Support Center